Financhill
Back

Solid Biosciences Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
25

SLDB
Solid Biosciences

Last Price:
7.96
Seasonality Move:
6.12%
Sell
37

SRPT
Sarepta Therapeutics

Last Price:
127.11
Seasonality Move:
0.19%
Sell
25
Solid Biosciences (SLDB) is a Sell

Is Solid Biosciences a Buy, Sell or Hold?

  • The current Solid Biosciences [SLDB] share price is $7.15. The Score for SLDB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • SLDB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SLDB Stock Price Chart

What is Solid Biosciences's stock price today?

  • The Solid Biosciences share price today is $7.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLDB is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $125.01
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

SLDB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 36.32 Sell
Chaikin Money Flow: -257041 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.81 - 9.31) Sell
Bollinger Bands (100): (7.05 - 9.41) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.92 Sell
Relative Strength Index (14 RSI): 32.69 Sell
Chaikin Money Flow: -233066 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (127.43 - 139.51) Sell
Bollinger Bands (100): (124.47 - 147.63) Sell

SLDB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.66 Sell
20-day SMA: 8.46 Sell
50-day SMA: 8.43 Sell
200-day SMA: 8.46 Sell
8-day EMA: 7.66 Sell
20-day EMA: 8.08 Sell
50-day EMA: 8.24 Sell
200-day EMA: 7.97 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.01 Sell
20-day SMA: 132.96 Sell
50-day SMA: 138.54 Sell
200-day SMA: 126.19 Sell
8-day EMA: 126.73 Sell
20-day EMA: 130.78 Sell
50-day EMA: 134.9 Sell
200-day EMA: 128.87 Sell

Solid Biosciences Earnings Growth & SLDB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.56 per share, an increase next quarter of $0.03 per share, an increase this year of $2.12 per share, and an increase next year of $0.14 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Solid Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):